RxDoctor Payments Data

Geetha Puri, MD

Psychiatry · Victorville, CANPI 1336312446

Payments from drug & device makers

$248in general payments, 2019–2025

Across 18 payments — averaging $13.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$107
  • Lundbeck LLC$51
  • AbbVie$25
  • Boston Scientific$19
  • Alkermes, Inc.$18
  • GSK$15
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$248100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$248 in reported general payments places this provider in the 50th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$28,952
Medicare patients
72
Services billed
343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$190,964
VraylarCariprazine Hcl23$31,429
TrintellixVortioxetine Hydrobromide53$24,973
LybalviOlanzapine/Samidorphan Malate15$23,934
Lurasidone Hcl56$18,963
LatudaLurasidone Hcl11$14,940
VyvanseLisdexamfetamine Dimesylate11$3,927
Quetiapine Fumarate273$3,746
Quetiapine Fumarate ErQuetiapine Fumarate34$2,544
Bupropion XlBupropion Hcl222$2,422
Hydroxyzine Pamoate237$2,408
Divalproex Sodium ErDivalproex Sodium115$2,133
Aripiprazole98$1,585
Duloxetine Hcl114$1,225
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine80$1,167

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$13$190,96413 claims
AbbVieVraylar$25$31,42923 claims
Alkermes, Inc.Lybalvi$18$23,93415 claims
Sunovion Pharmaceuticals Inc.Latuda$107$14,94011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Victorville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →